Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Reader Login
  Users Online: 581Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2020| July-September  | Volume 11 | Issue 3  
    Online since July 6, 2020

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLE
COVID-19 effect on clinical research: Single-site risk management experience
Fatma Soliman Elsayed Ebeid
July-September 2020, 11(3):106-110
DOI:10.4103/picr.PICR_119_20  
  1 3,112 569
EDITORIAL
Real-world data in COVID-19 pandemic: An essential unmet health-care need
Arun Bhatt
July-September 2020, 11(3):103-105
DOI:10.4103/picr.PICR_168_20  
  - 3,189 598
ETHICS EDUCATION
Ethics committee meetings – Online or face to face?
Ravindra Bhaskar Ghooi
July-September 2020, 11(3):121-123
DOI:10.4103/picr.PICR_97_20  
  - 1,063 202
INVESTIGATOR INSIGHTS
Addressing challenges due to the COVID-19 pandemic – A site and investigator perspective
Priya Ranganathan, Deepa Nair, Nithya Jaideep Gogtay
July-September 2020, 11(3):111-114
DOI:10.4103/picr.PICR_165_20  
  - 2,784 515
LETTER TO EDITOR
Prerequisite of doing clinical trial with drugs in COVID-19 patients: Situational experience
Pugazhenthan Thangaraju, Atul Jindal
July-September 2020, 11(3):135-135
DOI:10.4103/picr.PICR_184_20  
  - 578 108
MEDICAL AFFAIRS
Medical affairs post-COVID 19: Are we ready to take the baton?
Viraj Deodatta Rajadhyaksha
July-September 2020, 11(3):124-127
DOI:10.4103/picr.PICR_164_20  
  - 2,433 436
PHARMACOVIGILANCE PERSPECTIVES
Pharmacovigilance and assessment of drug safety reports during COVID 19
Mira K Desai
July-September 2020, 11(3):128-131
DOI:10.4103/picr.PICR_171_20  
  - 1,740 303
REGULATORY UPDATE
Indian regulatory update during the COVID-19 pandemic
Amita Chandan Bhave
July-September 2020, 11(3):132-134
DOI:10.4103/picr.PICR_182_20  
  - 1,653 253
SPONSOR STRATEGIES
Challenges and opportunities for sponsors in conducting clinical trials during a pandemic
Sanish Davis, Seema Pai
July-September 2020, 11(3):115-120
DOI:10.4103/picr.PICR_177_20  
  - 3,381 487
  Feedback 
  Subscribe